Hepatitis C: Community of Practice

Alternate Thursdays, noon - 1 p.m.

9/23/2021

This 16 session Hepatitis C Community of Practice ECHO series will help build or improve systems of care that effectively treat hepatitis C in the primary care setting with the aim of eliminating hepatitis C from your clinical setting and community. The Community of Practice is offered to any primary care team or clinician that has participated in a previous Hepatitis C and Liver Care ECHO program.  Other Oregon clinicians and their teams treating hepatitis C will be accepted based on interest, geographic distribution throughout Oregon, and ability to commit to the sessions.

*Accreditation: Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit: OHSU School of Medicine designates this live activity for a maximum of 16.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Credit: Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Hepatitis C Community of Practice has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: 

  • Family Medicine
  • Preventive Medicine
  • Psychiatry and Neurology

This program is registered for MOC part II through the American Board of Internal Medicine (ABIM).

5/12/2022


Session/Title Date
0 - Standing Resources 3/1/2021
1 - Developing Leadership Buy In 9/23/2021
2 - The role of information technology and developing a care cascade report 10/7/2021
3 - Building your Team 10/21/2021
4 - Prior Authorization Process 11/4/2021
5 - Developing Community Partner Networks 11/18/2021
6 - Literature Review 12/9/2021
7 - Engaging and maintaining engagement in the difficult to treat 1/6/2022
8 - Pharmacy Driven Treatment HCV 1/20/2022
9 - Updates on HCV and Reproductive Health 2/3/2022
10 - Case management from diagnosis to cure 2/17/2022
11 - CCC program data: Lab Bundle and Care Cascade Disparities 3/3/2022
12 - Ensuring Vaccination During HCV Treatment 3/17/2022
13 - Management and prognosis in ESLD 3/31/2022
14 - Monitoring of Cirrhotic Patients 4/14/2022
15 - Integrating Harm Reduction with HCV treatment 4/28/2022
16 - HCV Treatment in Decompensated Cirrhosis, Part 2 5/12/2022
Sign Up For This ECHO